Obesity is considered as a major risk factor for several pathological disorders, including diabetes, hypertension, atherosclerosis and cancer [1] . Obesity is also regarded as a cosmetic problem in modern days. Obesity stems from a prolonged imbalance between the levels of energy intake and expenditure, with the surplus being stored as body lipids. Diet is considered as an important factor in the development of obesity. Especially, increased fat intake is highly associated with body weight gain which can lead to obesity and other related metabolic diseases [2, 3] .
Energy intake from fat starts with its digestion into monoglycerides and fatty acids, catalyzed by lipase. Among the lipases pancreatic lipase is responsible for the hydrolysis of 50-70% of total dietary fats. Therefore, inhibition of pancreatic lipase is suggested to be an effective therapy in the regulation of obesity, by reducing the digestion and absorption of fat [4] . Orlistat, a specific pancreatic lipase inhibitor, has been clinically used for the prevention of obesity [5, 6] .
The rhizomes of Anemarrhena asphodeloides Bunge (Liliaceae) are widely distributed in Asia, including Korea. In traditional medicine, the drug has been used as an antidiabetic, antipyretic and sedative agent [7] . Phytochemical studies reported steroidal saponins, xanthones, and benzophenones as bioactive constituents of A. asphodeloides [8] [9] [10] . Recently, several phenolic compounds have been reported to have antiadipogenic activity by the inhibition of adipocyte differentiation in 3T3-L1 cells [11] . However, little is known about the biological activity related to fat absorption through pancreatic lipase.
We have searched for pancreatic lipase inhibitory compounds from natural resources using porcine pancreatic lipase as an in vitro assay system. During the course of screening, the methanolic extract of A. asphodeloides rhizomes significantly inhibited this activity. The methanolic extract was further fractionated into n-hexane, CH 2 Cl 2 , EtOAc and n-BuOH fractions. Of these, the EtOAc-soluble fraction showed the most potent inhibition of pancreatic lipase activity ( Figure 1 ). Further fractionation and separation of the EtOAcsoluble fraction by several chromatographic methods yielded twelve compounds (Figure 2A ). The presence of a glucosyl moiety was easily deduced from an anomeric proton at δ H 4.61 (1H, d, J = 7.6 Hz) and an anomeric carbon at δ C 104.9, together with five glucosyl carbons at δ C 76.9, 76.3, 73.7, 69.6 and 61.1 in the HSQC spectrum. In the 13 C NMR spectrum, 13 additional carbons including a carbonyl carbon (δ C 196.3) and 12 aromatic carbons indicated the presence of a benzophenone. The position of a glucosyl moiety was determined to be C-2 by the correlation between δ H 4.61 (H-1'', anomeric proton) and δ C 142.2 (C-2) in the HMBC spectrum ( Figure 2B ). The position of a methoxyl moiety was determined to be C-4 by the correlation between δ H 3.95 (OCH 3 ) and δ C 150.9 (C-4) in the HMBC spectrum, as well as correlation between δ H 3.95 (OCH 3 ) and δ H 6.92 (H-5) in the NOESY spectrum ( Figure 2B ). On the basis of the obtained data, compound 1 was determined, as shown, and named zimoside A. The structures of compounds 2-12 were identified as four benzophenones, iriflophenone (2), 2,4',6-trihydroxy-4methoxybenzophenone (3), foliamangiferoside A (4) and 2,3dihydroxy-4-methoxyphenyl)(4-hydroxyphenyl)-methanone (5), one xanthone, 1,4,5,6,-tetrahydroxyxanthone (6), one flavonoid, isosakuranetin (7) , four phenolic compounds, 4-hydroxybenzoic acid (8), 4-hydroxyacetophenone (9), vanillic acid (10), and tyrosol (11) , and one furan, 5-hydroxymethyl-2-furaldehyde (12) ( Figure  2A ), by direct comparison of their physicochemical and spectroscopic data with those previously reported [12] [13] [14] [15] [16] .
Pancreatic lipase activity of the isolated compounds 1-12 was assessed by employing porcine pancreatic lipase using nitrophenylbutyrate (p-NPB) as a substrate. Among the isolated compounds, 3, 5 and 10 showed significant inhibitory activity against pancreatic lipase (Figure 3 ). Compounds 1-5 are benzophenone derivatives and differ in numbers and positions of hydroxyl, methoxyl and glucosyl moieties. Compound 1 has an identical structure to compound 5, except for the presence of a glucosyl moiety, however, only compound 5 showed significant inhibition of pancreatic lipase activity. Compounds 2 and 3 have the same structures except for the absence of a methoxyl group in the R 3 position of compound 2, but only compound 3 showed significant inhibitory activity in our assay system. These results suggested that the methoxyl moiety of benzophenone showed a positive effect, whereas a glucosyl moiety had a negative effect on the inhibition by benzophenones on pancreatic lipase.
Compound 10, which has a methoxyl group in its structure also showed significant inhibition of pancreatic lipase. However, compounds 7 and 9 showed little effect on pancreatic lipase activity, although both have methoxyl groups in their structures. Therefore, more derivatives need to be investigated for a better understanding of the structure activity relationship related to pancreatic lipase inhibition. In addition, the inhibitory effects on pancreatic lipase need to be clarified using other substrates, such as emulsified triglycerides, by comparing the potencies of the isolated compounds depending on the forms of substrate.
Excessive total fat mass is a characteristic feature of obesity and arises from chronic imbalance between energy intake and energy expenditure. Energy intake starts from fat absorption through digestion of fat into monoglycerides and fatty acids, catalyzed by lipases. Absorbed fat is further accumulated into adipose tissue, which is called adipocyte differentiation [17] . Therefore, inhibition of both fat absorption and fat accumulation is suggested to be an effective therapy in the treatment of obesity [18] . Natural products contain diverse constituents, which allow multiple activities. Our present study shows the inhibitory effect of the EtOAc-soluble fraction of A. asphodeloides and its active constituents, benzophenones, on pancreatic lipase activity. The EtOAc fraction of A. asphodeloides and its phenolic compounds have been reported to have an inhibitory activity on adipocyte differentiation [13] . Therefore, A. asphodeloides is suggested to be beneficial for the treatment of obesity by the combined inhibitory action of these constituents on both pancreatic lipase and adipocyte differentiation.
Experimental
Plant material: The dried rhizomes of A. asphodeloides were purchased from a local herbal market in Chungbuk, Korea in December 2011. They were identified by the herbarium of the College of Pharmacy at Chungbuk National University, where a voucher specimen was deposited (CBNU201112-AA).
Isolation of compounds:
The dried rhizomes of A. asphodelodes (1.0 kg) were extracted 3 times with 80% MeOH, which yielded the methanolic extract (410.5 g). This was then suspended in H 2 O and partitioned successively with n-hexane, CH 2 Cl 2 , EtOAc and n-BuOH. The EtOAC fraction (2.1 g), which showed most potent inhibitory activity, was subjected to CC on silica gel eluting with a mixture of CH 2 Cl 2 -MeOH with an increasing proportion of MeOH to give 10 fractions (AS-E1 -AS-E12). AS-E1 was subjected to CC over Sephadex LH-20 eluted with CH 2 Cl 2 -MeOH (1:1) and semipreparative HPLC eluting with MeOH-water (45:55, v/v) to give compounds 9, 11 and 12. Compounds 3 and 5 were purified from AS-E2 by semi-preparative HPLC eluting with MeOH-water (50:50, v/v). Compound 7 was purified from AS-E3 by CC on RPsilica and semi-preparative HPLC. CC of AS-E4 over Sephadex Anemarrhena asphodeloides and pancreatic lipase activity 13 
Measurement of pancreatic lipase activity:
Pancreatic lipase inhibitory activity was evaluated using previously reported methods with minor modification [7, 9] . Briefly, enzyme solution was prepared by the reconstitution of porcine pancreatic lipase (Sigma, St. Louis, MO) in 0.1M Tris-HCl buffer (pH 8). Then, test sample was mixed with enzyme buffer, and incubated for 15 min at 37 °C. After incubation, 10 Mm p-nitrophenylbutyrate (p-NPB) was added and the enzyme reaction was allowed to proceed for 15 min at 37°C. Pancreatic lipase activity was determined by measuring the hydrolysis of p-NPB to p-nitrophenol at 405 nm using a microplate reader. Inhibition of lipase activity was expressed as the percentage decrease in the OD when incubated with the test compounds. Orlistat (Sigma, St. Louis, MO) was used as a positive control.
Statistical analysis:
The evaluation of statistical significance was determined by one-way ANOVA test with a value of p < 0.05 or less considered to be statistically significant.
